Search research articles
Contact Us
Filters
Showing results (71-80 of 114) with videos related to
Page
of 12
Sort By:
Anti-Cancer Drugs
|
June 5, 2002
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer
F Honecker, C Kollmannsberger, D Quietzsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis
C Bokemeyer, C Kollmannsberger, C Meisner, et al.
Anticancer Research
|
March 28, 2001
Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide
J T Hartmann, L M Fels, A Franzke, et al.
World Journal of Urology
|
June 29, 2004
Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience
M A Kuczyk, C Bokemeyer, C Kollmannsberger, et al.
British Journal of Cancer
|
July 9, 2004
Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial
R-D Hofheinz, J T Hartmann, A Willer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 6, 2008
Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group
M Schlemmer, P Reichardt, J Verweij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2004
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer
O Rick, C Bokemeyer, S Weinknecht, et al.
Der Urologe. Ausg. A
|
July 1, 1998
[Prognostic relevance of vena cava thrombosis in renal cell carcinoma]
M A Kuczyk, G Köhn, K Höfner, et al.
British Journal of Cancer
|
December 4, 2003
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study
J T Hartmann, K Oechsle, D Quietzsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2004
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group
C Kollmannsberger, J Beyer, R Liersch, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 114) with videos related to
Sort By:
Page
of 12
Anti-Cancer Drugs
|
June 5, 2002
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer
F Honecker, C Kollmannsberger, D Quietzsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis
C Bokemeyer, C Kollmannsberger, C Meisner, et al.
Anticancer Research
|
March 28, 2001
Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide
J T Hartmann, L M Fels, A Franzke, et al.
World Journal of Urology
|
June 29, 2004
Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience
M A Kuczyk, C Bokemeyer, C Kollmannsberger, et al.
British Journal of Cancer
|
July 9, 2004
Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial
R-D Hofheinz, J T Hartmann, A Willer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 6, 2008
Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group
M Schlemmer, P Reichardt, J Verweij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2004
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer
O Rick, C Bokemeyer, S Weinknecht, et al.
Der Urologe. Ausg. A
|
July 1, 1998
[Prognostic relevance of vena cava thrombosis in renal cell carcinoma]
M A Kuczyk, G Köhn, K Höfner, et al.
British Journal of Cancer
|
December 4, 2003
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study
J T Hartmann, K Oechsle, D Quietzsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 2004
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group
C Kollmannsberger, J Beyer, R Liersch, et al.
Page
of 12